SOLICITATION NOTICE
65 -- Synthesis and Delivery of 115mg Anti-Butyrylcholinesterase Antibody - Sole Source Justification
- Notice Date
- 7/3/2018
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 2018-24607
- Archive Date
- 8/2/2018
- Point of Contact
- Adam Lorimer, Phone: 4044985611
- E-Mail Address
-
oga5@cdc.gov
(oga5@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- Sole Source Justification Synthesis and Delivery of 115mg Anti-Butyrylcholinesterase Antibody The Emergency Response Branch (ERB) has developed several highly-specific and sensitive methods that require the highest quality reagents to meet CLIA specifications. Many of these methods rely on the specificity and reproducibility of the BioPorto butyrylcholinesterase antibody. These CLIA standards require antibody specificity and quality that only BioPorto can provide. Other companies have been considered, such as Thermo Scientific, but they redistribute the BioPorto antibody and cannot provide it in the quantities required by the ERB within our timeline. Purchasing this specific product ensures continuity of branch methodology and continual adherence to CLIA standards.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2018-24607/listing.html)
- Record
- SN04978472-W 20180705/180703230956-ac83de7a8b1f9ac99b99b12c81111a12 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |